Clinical trial
"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"
NCT05355597 is registered in ClinicalTrials.gov with Atlantic Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"
- Lead sponsor
- Atlantic Health System
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 27, 2021
- Completion date
- March 24, 2025
- Enrollment
- 116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
musculoskeletal diseases, soft tissue mass